A collaboration between Clinerion’s data driven Patient Recruitment System and the direct, individualized patient/physician engagement offered by eClinicalHealth’s Clinpal provides complementary support and synergies throughout the clinical trials process.
Basel, Switzerland – Clinerion and eClinicalHealth, innovative companies working in the area of electronic patient recruitment, announce a collaboration between the two companies and their respective platforms, Clinerion’s Patient Recruitment System and eClinicalHealth’s Clinpal. Under the terms of the collaboration, Clinerion and eClinicalHealth will leverage the complementary nature of their respective technologies by offering them in tandem to hospitals and sponsor companies/CROs. Clinerion and eClinicalHealth touch the clinical trials process at different and complementary points. Clinerion’s Patient Recruitment System (PRS) supports the clinical trial process by identifying and recruiting suitable patients through real-time search of millions of Electronic Healthcare Records (EHRs) within its growing global network of participating hospitals. eClinicalHealth’s Clinpal represents a comprehensive electronic platform for engaging and recruiting patients through direct patient facing web solutions, while at the same time running sophisticated workflows which guide both the patient and the site through the clinical trial process. Together, these two technologies have the potential to augment each other’s effect by combining Clinerion’s powerful Big Data tools with the direct, individualized patient/physician engagement offered by Clinpal. “We are excited about the new horizons this collaboration offers for our clients” says Ulf Claesson, CEO of Clinerion. “Clinerion’s PRS quickly fills the patient pool of a study with suitable candidates using our patented search technology. Clinpal further replenishes this pool by making sure we capture individual patients directly, and prevents leaks by engaging with patients and improving their experience of the study.” “The Clinpal Team is eager to engage with Clinerion to advance technology-enabled clinical trials. Together, we can deliver enhanced patient engagement, reduce site burden, and expedite working practices on behalf of CROs and our joint Sponsors,” says Karl Landert, Chairman of the Board and CEO of eClinicalHealth.
About eClinicalHealth
Headquartered in Scotland, eClinicalHealth Limited, developers of the revolutionary Clinpal patient engagement platform, was founded in early 2012 to provide innovative clinical trial solutions. The company is committed to leading open and collaborative innovation discussions about patient centric clinical trial processes and technology with pharmaceutical companies, CROs and other service and technology providers. eClinicalHealth website:
www.clinpal.com
About Clinerion
Clinerion is an international technology services company offering highly scalable electronic patient recruitment solutions to increase efficiency and quality in clinical research. The company's Patient Recruitment System connects to and leverages existing electronic medical records. Following international privacy and confidentiality standards, Clinerion's solutions pseudonimyze, enrich and normalize those records and facilitate real-time patient recruitment for clinical trials. Clinerion website:
www.clinerion.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
The State of the Opioid Epidemic
March 26th 2024In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.